Treffer 1 - 4 von 4 für Suche 'Abulikemu, Kailibinuer', Suchdauer: 0,36s Treffer weiter einschränken
  1. 1
    Targeting therapy in pemphigus: Where are we now and where are we going?

    Targeting therapy in pemphigus: Where are we now and where are we going? von Abulikemu, Kailibinuer, Hu, Fengxia, Liang, Junqin, Kang, Xiaojing

    Veröffentlicht in Heliyon

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Safety and Efficacy of Nemolizumab for Atopic Dermatitis With Pruritus: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials

    Safety and Efficacy of Nemolizumab for Atopic Dermatitis With Pruritus: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials von Liang, Junqin, Hu, Fengxia, Dan, Maoli, Sang, Yingbing, Abulikemu, Kailibinuer, Wang, Qian, Hong, Yongzhen, Kang, Xiaojing

    Veröffentlicht in Frontiers in immunology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Nine cases of refractory bullous pemphigoid treated with dupilumab and literature review

    Nine cases of refractory bullous pemphigoid treated with dupilumab and literature review von Liang, Junqin, Abulikemu, Kailibinuer, Maolidan, Hu, Fengxia, Zhao, Juan, Qiu, Yun, Wang, Qian, Sang, Yingbing, Hong, Yongzhen, Kang, Xiaojing


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Interleukin‐37 inhibits desmoglein‐3 endocytosis and keratinocyte dissociation via upregulation of Caveolin‐1 and inhibition of the STAT3 pathway

    Interleukin‐37 inhibits desmoglein‐3 endocytosis and keratinocyte dissociation via upregulation of Caveolin‐1 and inhibition of the STAT3 pathway von Liang, Junqin, Hu, Fengxia, Mao, Lidan, Qiu, Yun, Jiang, Fanhe, Wang, Qian, Abulikemu, Kailibinuer, Hong, Yongzhen, Ge, Xinyu, Kang, Xiaojing


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: